CD81 and periodontitis: To assess the effect of ABT263 on eliminating CD81+ fibroblasts in periodontitis, IF staining demonstrated a drop in the proportion of CD81+ fibroblasts from 40% to less than 20% after treatment (Figure 6E, c).